Novartis Chief Executive Vas Narasimhan, facing an uproar over data manipulation involving $2.1 million gene therapy Zolgensma, pledged on Monday to tell regulators quickly if credible questions emerge in future over data integrity.
from Reuters: Health News https://ift.tt/303E8XF
via
IFTTT
0 comments:
Post a Comment